After being recognized as one of the Top 10 Best Annual Reports of 2022, Imexpharm received more good news with the inclusion of its IMP stock in the VNSI (VN Sustainability Index) on the HOSE exchange. Notably, it is the only stock from the Healthcare sector included in this prestigious index.
The VNSI Sustainability Index was established by the Ho Chi Minh Stock Exchange (HOSE) in 2017 as a reference tool or as an underlying asset for future ETF products and index derivatives, helping investors identify investment opportunities that could bring long-term value. The index is calculated based on the "Sustainability Index Basket," which includes 20 stocks from 20 companies with the highest sustainability scores on the exchange, assessed every six months.
According to the announcement from HOSE, Imexpharm’s IMP stock was added to the latest Sustainability Index Basket in the July 2022 evaluation report (published on November 30). Notably, the IMP stock is the only stock from the Healthcare sector included in this round of the index. The fact that Imexpharm’s stock has stood out among its industry peers highlights the effectiveness of the company’s sustainability strategy, which has been recognized in practice.
This move by HOSE reflects a high regard for Imexpharm’s transparency, reliability, and, especially, its governance effectiveness, among more than 530 listed securities on the exchange. It is a proud recognition of the values the leadership and team have diligently built, preserved, and developed to ensure the company’s sustainable mission of providing effective health solutions for the community.
Congratulations to the entire Imexpharm team on this achievement!